busulfan has been researched along with Hypertension, Portal in 6 studies
Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lassau, N | 1 |
| Leclère, J | 1 |
| Auperin, A | 1 |
| Bourhis, JH | 1 |
| Hartmann, O | 1 |
| Valteau-Couanet, D | 1 |
| Benhamou, E | 1 |
| Bosq, J | 1 |
| Ibrahim, A | 1 |
| Girinski, T | 1 |
| Pico, JL | 1 |
| Roche, A | 1 |
| Foadi, MD | 1 |
| Shaw, S | 1 |
| Paradinas, FJ | 1 |
| Shepherd, PC | 1 |
| Fooks, J | 1 |
| Gray, R | 1 |
| Allan, NC | 1 |
| Shepherd, P | 1 |
| Harrison, DJ | 1 |
| Kelsey, PR | 1 |
| Geary, CG | 1 |
| Ward, HP | 1 |
| Block, MH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients[NCT03963999] | Phase 4 | 0 participants (Actual) | Interventional | 2020-04-01 | Withdrawn (stopped due to We did not receive grant funding. We will reapply in June of 2020) | ||
| Usefulness of Liver Stiffness Measurement in Predicting Hepatic Veno-Occlusive Disease Development in Patients Who Undergo HSCT: a Multicentric Prospective Study[NCT03426358] | 1,101 participants (Actual) | Interventional | 2015-04-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for busulfan and Hypertension, Portal
| Article | Year |
|---|---|
Management of idiopathic myelofibrosis.
Topics: Anemia; Ascites; Blood Coagulation Disorders; Bone Marrow; Busulfan; Chlorambucil; Humans; Hypertens | 1987 |
The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.
Topics: Adrenal Cortex Hormones; Alkaline Phosphatase; Androgens; Anemia; Animals; Blood Cell Count; Blood C | 1971 |
1 trial available for busulfan and Hypertension, Portal
| Article | Year |
|---|---|
Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension. Results from MRC CML. II. Trial comparing busulphan with busulphan and thioguanine.
Topics: Alkaline Phosphatase; Ascites; Bilirubin; Busulfan; Chemical and Drug Induced Liver Injury; Esophage | 1991 |
3 other studies available for busulfan and Hypertension, Portal
| Article | Year |
|---|---|
Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients.
Topics: Adult; Busulfan; Child; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem C | 1997 |
Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients.
Topics: Adult; Busulfan; Child; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem C | 1997 |
Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients.
Topics: Adult; Busulfan; Child; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem C | 1997 |
Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients.
Topics: Adult; Busulfan; Child; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem C | 1997 |
Portal hypertension in a patient with chronic myeloid leukaemia.
Topics: Busulfan; Humans; Hypertension, Portal; Leukemia, Myeloid; Liver; Male; Middle Aged | 1977 |
Idiopathic portal hypertension associated with cytotoxic drugs.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Female; Hodgkin Disease; Humans; Hy | 1990 |